AUTL - Autolus Therapeutics GAAP EPS of -$0.46 misses by $0.13 August, 04 2022 07:12 AM Autolus Therapeutics plc Autolus Therapeutics press release ( NASDAQ: AUTL ): Q2 GAAP EPS of -$0.46 misses by $0.13 . Cash at Q2 totaled $216.4 million, as compared to cash of $310.3 million at December 31, 2021. For further details see: Autolus Therapeutics GAAP EPS of -$0.46 misses by $0.13